Status:

COMPLETED

Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients

Lead Sponsor:

Walter Reed Army Medical Center

Collaborating Sponsors:

National Kidney Foundation, United States

Conditions:

Kidney Failure, Chronic

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of the investigators study is to assess the impact of therapy with Pentoxifylline (PTF), a nonspecific phosphodiesterase inhibitor, on kidney function in patients at high-risk for progress...

Detailed Description

The treatment objective for chronic kidney disease (CKD), regardless of etiology, is to slow or halt progression of renal dysfunction and reduce proteinuria (in those patients with proteinuric renal d...

Eligibility Criteria

Inclusion

  • Patients 18 years of age or older currently being treated with an ACE-I or ARB and with one of the following conditions:
  • Non-nephrotic range proteinuria (between 1 and 3 grams/day by 24-hr collection), hypertension (blood pressure \>130/80 or current use of antihypertensive drug therapy), and an eGFR of less than or equal to 40 ml/minute but greater than 20 ml/minute.
  • OR
  • Nephrotic range proteinuria (\>=3 grams/day proteinuria) by 24-hr urine collection, and an eGFR greater than 20 ml/minute

Exclusion

  • Acute renal failure: defined by \>25% decrease in eGFR over one month
  • Pregnancy or currently breast-feeding
  • Current use of cytotoxic drug therapy (cyclophosphamide, cyclosporine, mycophenolate mofetil, prednisone, chlorambucil) or a current indication for, and plan to implement, such therapy.
  • Current use of PTF
  • Contraindication to use of PTF drug: history of PTF or theophylline allergy, history of severe retinal hemorrhage or recent cerebral hemorrhage
  • Current use of theophylline
  • Contraindication to ACE-I or ARB.
  • Fewer than 2 measured serum creatinine values separated by 6 months prior to potential enrollment

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT00285298

Start Date

January 1 2006

End Date

April 1 2008

Last Update

July 29 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients | DecenTrialz